Medicare Enrolled
Dr. Lawrence Foote, M.D.
Medical Oncology · Houston, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Foote from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Foote?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Foote
Dr. Lawrence Foote is a medical oncology specialist in Houston, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Foote performed 1,682 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Foote received a total of $2,387 from 37 pharmaceutical and/or device companies across 132 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Foote is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 49% volume in TX
$2,387 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,682
Medicare services
Top 49% in TX for medical oncology
Not available
Unique patients (not deduplicated)
$33
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
318 | $8 | $20 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
279 | $65 | $250 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
276 | $8 | $36 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
230 | $0 | $1 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
109 | $62 | $247 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
49 | $11 | $96 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
39 | $104 | $707 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
36 | $23 | $157 |
| New patient office visit, complex (60-74 min) | 35 | $174 | $709 |
| Reticulated platelet measurement A blood test that measures the level of young, newly formed platelets in the body. |
34 | $35 | $143 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
33 | $12 | $108 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
32 | $4 | $22 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
32 | $6 | $34 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
30 | $52 | $313 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
28 | $4 | $23 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
27 | $116 | $565 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
26 | $45 | $150 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
26 | $136 | $694 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
22 | $5 | $26 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
21 | $103 | $368 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
6.2% high complexity
18.5% medium
75.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,387
Total received (2018-2024)
Avg $341/year across 7 years
Bottom 41% in TX for medical oncology
37
Companies
132
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$792
2023
$751
2022
$271
2021
$37
2020
$22
2019
$281
2018
$233
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$158
PFIZER INC.
$122
SEAGEN INC.
$90
Celgene Corporation
$53
Incyte Corporation
$45
Tempus AI, Inc
$44
SOBI, INC
$34
SpringWorks Therapeutics, Inc.
$33
ARRAY BIOPHARMA INC
$30
AstraZeneca Pharmaceuticals LP
$26
E.R. Squibb & Sons, L.L.C.
$23
BeiGene USA, Inc.
$23
Gilead Sciences, Inc.
$22
Pharmacosmos Therapeutics Inc.
$20
GENZYME CORPORATION
$19
Exelixis Inc.
$19
PUMA BIOTECHNOLOGY, INC.
$16
Astellas Pharma US Inc
$14
Top 3 companies account for 46.7% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$617
Novartis Pharmaceuticals Corporation
$444
Celgene Corporation
$176
Gilead Sciences, Inc.
$105
SEAGEN INC.
$90
SECURA BIO, INC.
$90
Puma Biotechnology, Inc.
$67
Boehringer Ingelheim Pharmaceuticals, Inc.
$56
GENZYME CORPORATION
$47
Merck Sharp & Dohme LLC
$45
Incyte Corporation
$45
Tempus AI, Inc
$44
AstraZeneca Pharmaceuticals LP
$42
SOBI, INC
$34
SpringWorks Therapeutics, Inc.
$33
ARRAY BIOPHARMA INC
$30
Apellis Pharmaceuticals, Inc.
$28
ImmunoGen, Inc.
$27
CTI BioPharma Corp.
$26
GlaxoSmithKline, LLC.
$25
INSYS Therapeutics Inc
$24
E.R. Squibb & Sons, L.L.C.
$23
BeiGene USA, Inc.
$23
Genentech USA, Inc.
$22
Sobi, Inc
$22
Pharmacosmos Therapeutics Inc.
$20
PharmaEssentia USA Corporation
$20
Exelixis Inc.
$19
Stemline Therapeutics Inc.
$18
Karyopharm Therapeutics Inc.
$18
Janssen Pharmaceuticals, Inc
$18
Takeda Pharmaceuticals U.S.A., Inc.
$18
Kite Pharma, Inc.
$16
PUMA BIOTECHNOLOGY, INC.
$16
Astellas Pharma US Inc
$14
Seattle Genetics, Inc.
$12
Acrotech Biopharma LLC
$12
Top 3 companies account for 51.8% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · BELEODAQ · BESPONSA · BESREMI · BOSULIF · CABOMETYX · COPIKTRA · COSELA · DOPTELET · ENHERTU · Elahere · Fabhalta · GAZYVA · GILOTRIF · IBRANCE · IMJUDO · INLYTA · JAKAFI · KEYTRUDA · KISQALI · LORBRENA · MONJUVI · MYLOTARG · NERLYNX · OGSIVEO · OJJAARA · OPDIVO · Orserdu · PADCEV · PROMACTA · Pomalyst · REBLOZYL · SARCLISA · SCEMBLIX · SYNDROS · TALZENNA · TEVIMBRA · Trodelvy · VONJO · VYNDAQEL · Vonjo · XARELTO · XPOVIO · XTANDI · XYNTHA · Xtandi · Yescarta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
185
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Foote is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Foote experienced with blood draw (venipuncture)?
Based on Medicare claims data, Dr. Foote performed 318 blood draw (venipuncture) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Foote receive payments from pharmaceutical companies?
Yes. Dr. Foote received a total of $2,387 from 37 companies across 132 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Foote's costs compare to other medical oncologists in Houston?
Dr. Foote's average Medicare payment per service is $33. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Foote) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Houston
Browse medical oncologists in Houston ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in TX
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in TX
Which TX medical oncologists receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology